Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5502)
All Articles published online
|
Mar 14, 2012 (publication date) through Jun 21, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chen Y, Shi M, Yu GZ, Qin XR, Jin G, Chen P, Zhu MH. Interleukin-8, a promising predictor for prognosis of pancreatic cancer. World J Gastroenterol 2012; 18(10): 1123-1129 [PMID: 22416189 DOI: 10.3748/wjg.v18.i10.1123] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i10/1123.htm |
| Number | Citing Articles |
| 1 |
Betul Celik, Arzu Didem Yalcin, Gizem Esra Genc, Tangul Bulut, Sibel Kuloglu Genc, Saadet Gumuslu. CXCL8, IL-1β and sCD200 are pro-inflammatory cytokines and their levels increase in the circulation of breast carcinoma patients. Biomedical Reports 2016; 5(2): 259 doi: 10.3892/br.2016.709
|
| 2 |
Rui Zhong, Xin Jiang, Yan Peng, Huan Xu, Yongfeng Yan, Li Liu, Xiaowei Tang, Surinder K. Batra. A nomogram prediction of overall survival based on lymph node ratio, AJCC 8th staging system, and other factors for primary pancreatic cancer. PLOS ONE 2021; 16(5): e0249911 doi: 10.1371/journal.pone.0249911
|
| 3 |
Yamin Yan, Yan Hu, Zhenghong Yu, Yuxia Zhang. Association of the longitudinal trajectory of IL-8 with outcomes in critical patients after major surgery. Asian Journal of Surgery 2023; 46(5): 2196 doi: 10.1016/j.asjsur.2022.11.095
|
| 4 |
Mitra Elmi, Joshua H. Dass, Crispin R. Dass. The Various Roles of PEDF in Cancer. Cancers 2024; 16(3): 510 doi: 10.3390/cancers16030510
|
| 5 |
Chun-Ye Zhang, Shuai Liu, Ming Yang. Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression. World Journal of Gastrointestinal Oncology 2022; 14(8): 1456-1468 doi: 10.4251/wjgo.v14.i8.1456
|
| 6 |
Carlos Alfaro, Miguel F. Sanmamed, María E. Rodríguez-Ruiz, Álvaro Teijeira, Carmen Oñate, Álvaro González, Mariano Ponz, Kurt A. Schalper, José L. Pérez-Gracia, Ignacio Melero. Interleukin-8 in cancer pathogenesis, treatment and follow-up. Cancer Treatment Reviews 2017; 60: 24 doi: 10.1016/j.ctrv.2017.08.004
|
| 7 |
Satoshi Yuki, Kentaro Yamazaki, Yu Sunakawa, Hiroya Taniguchi, Hideaki Bando, Manabu Shiozawa, Tomohiro Nishina, Hisateru Yasui, Yoshinori Kagawa, Naoki Takahashi, Tadamichi Denda, Taito Esaki, Hisato Kawakami, Hironaga Satake, Atsuo Takashima, Nobuhisa Matsuhashi, Takeshi Kato, Chiharu Asano, Yukiko Abe, Shogo Nomura, Takayuki Yoshino. Role of plasma angiogenesis factors in the efficacy of first‐line chemotherapy combined with biologics in RAS wild‐type metastatic colorectal cancer: Results from the GI‐SCREEN CRC‐Ukit study. Cancer Medicine 2023; 12(18): 18702 doi: 10.1002/cam4.6486
|
| 8 |
Hyang-Mi Lee, Hye-Jin Lee, Ji-Eun Chang. Inflammatory Cytokine: An Attractive Target for Cancer Treatment. Biomedicines 2022; 10(9): 2116 doi: 10.3390/biomedicines10092116
|
| 9 |
Marilyn Masih, Sonam Agarwal, Rupinder Kaur, Pramod Kumar Gautam. Role of chemokines in breast cancer. Cytokine 2022; 155: 155909 doi: 10.1016/j.cyto.2022.155909
|
| 10 |
Wenwei Hao, Yongping Zhu, Huifang Zhou. Prognostic value of interleukin-6 and interleukin-8 in laryngeal squamous cell cancer. Medical Oncology 2013; 30(1) doi: 10.1007/s12032-012-0333-6
|
| 11 |
Chiara Bazzichetto, Fabiana Conciatori, Claudio Luchini, Francesca Simionato, Raffaela Santoro, Vanja Vaccaro, Vincenzo Corbo, Italia Falcone, Gianluigi Ferretti, Francesco Cognetti, Davide Melisi, Aldo Scarpa, Ludovica Ciuffreda, Michele Milella. From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer. Cells 2020; 9(2): 309 doi: 10.3390/cells9020309
|
| 12 |
Wojciech Błogowski, Tomasz Bodnarczuk, Teresa Starzyńska. Concise Review: Pancreatic Cancer and Bone Marrow-Derived Stem Cells. Stem Cells Translational Medicine 2016; 5(7): 938 doi: 10.5966/sctm.2015-0291
|
| 13 |
Zhihui Xiao, Wenjun Wu, Vladimir Poltoratsky. Metformin Suppressed CXCL8 Expression and Cell Migration in HEK293/TLR4 Cell Line. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/6589423
|
| 14 |
Wootae Kim, Jaehyuk Pyo, Byeong-Joo Noh, Joo-Won Jeong, Juhie Lee, Ja-Eun Kim. CCAR2 negatively regulates IL-8 production in cervical cancer cells. Oncotarget 2018; 9(1): 1143 doi: 10.18632/oncotarget.23199
|
| 15 |
Ya-Chin Hou, Chih-Jung Wang, Ying-Jui Chao, Hao-Yun Chen, Hao-Chen Wang, Hui-Ling Tung, Jung-Ting Lin, Yan-Shen Shan. Elevated Serum Interleukin-8 Level Correlates with Cancer-Related Cachexia and Sarcopenia: An Indicator for Pancreatic Cancer Outcomes. Journal of Clinical Medicine 2018; 7(12): 502 doi: 10.3390/jcm7120502
|
| 16 |
Gemma van Duijneveldt, Michael D.W. Griffin, Tracy L. Putoczki. Emerging roles for the IL-6 family of cytokines in pancreatic cancer. Clinical Science 2020; 134(16): 2091 doi: 10.1042/CS20191211
|
| 17 |
Giulio Giustarini, Germaine Teng, Andrea Pavesi, Giulia Adriani. Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1156769
|
| 18 |
Lanyun Feng, Qi Qi, Peng Wang, Hao Chen, Zhen Chen, Zhiqiang Meng, Luming Liu. Serum levels of IL-6, IL-8, and IL-10 are indicators of prognosis in pancreatic cancer. Journal of International Medical Research 2018; 46(12): 5228 doi: 10.1177/0300060518800588
|
| 19 |
Giuseppe Lucarelli, Vanessa Galleggiante, Monica Rutigliano, Antonio Vavallo, Pasquale Ditonno, Michele Battaglia. Isolation and Characterization of Cancer Stem Cells in Renal Cell Carcinoma. Urologia Journal 2015; 82(1): 46 doi: 10.5301/uro.5000099
|
| 20 |
Robert S O'Neill, Alina Stoita. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 2021; 27(26): 4045-4087 doi: 10.3748/wjg.v27.i26.4045
|
| 21 |
Hyun-Ah Kim, Hyunsoo Kim, Min-Kyung Nam, Jong Kook Park, Moo-Yeal Lee, Seok Chung, Kyung-Mi Lee, Hyo-Jeong Kuh. Suppression of the antitumoral activity of natural killer cells under indirect coculture with cancer-associated fibroblasts in a pancreatic TIME-on-chip model. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-03064-9
|
| 22 |
Gregory P. Takacs, Joseph A. Flores-Toro, Jeffrey K. Harrison. Modulation of the chemokine/chemokine receptor axis as a novel approach for glioma therapy. Pharmacology & Therapeutics 2021; 222: 107790 doi: 10.1016/j.pharmthera.2020.107790
|
| 23 |
Shuiliang Yu, Neetha Parameswaran, Ming Li, Yiwei Wang, Mark W. Jackson, Huiping Liu, Wei Xin, Lan Zhou. CRABP-II enhances pancreatic cancer cell migration and invasion by stabilizing interleukin 8 expression. Oncotarget 2017; 8(32): 52432 doi: 10.18632/oncotarget.14194
|
| 24 |
Zofia Marchewka, Beata Szymańska, Agnieszka Piwowar. The evaluation of urine concentration and diagnostic
usefulness of interleukin-8 and interleukin-18 in bladder cancer diagnostics
– preliminary report. Diagnostyka Laboratoryjna 2019; 54(2): 91 doi: 10.5604/01.3001.0013.7692
|
| 25 |
F. Chiellini, D. Puppi, A. M. Piras, A. Morelli, C. Bartoli, C. Migone. Modelling of pancreatic ductal adenocarcinoma in vitro with three-dimensional microstructured hydrogels. RSC Advances 2016; 6(59): 54226 doi: 10.1039/C6RA08420F
|
| 26 |
Jelena Milovanović, Nataša Todorović-Raković, Marko Radulovic. Interleukin-6 and interleukin-8 serum levels in prognosis of hormone-dependent breast cancer. Cytokine 2019; 118: 93 doi: 10.1016/j.cyto.2018.02.019
|
| 27 |
S M Wörmann, K N Diakopoulos, M Lesina, H Algül. The immune network in pancreatic cancer development and progression. Oncogene 2014; 33(23): 2956 doi: 10.1038/onc.2013.257
|
| 28 |
Krissi Danielsson, Daniel Ansari, Roland Andersson. Personalizing Pancreatic Cancer Medicine: What are the Challenges?. Personalized Medicine 2013; 10(1): 45 doi: 10.2217/pme.12.111
|
| 29 |
Leena Tiainen, Mari Hämäläinen, Tiina Luukkaala, Minna Tanner, Outi Lahdenperä, Pia Vihinen, Arja Jukkola, Peeter Karihtala, Eeva Moilanen, Pirkko-Liisa Kellokumpu-Lehtinen. Low Plasma IL-8 Levels During Chemotherapy Are Predictive of Excellent Long-Term Survival in Metastatic Breast Cancer. Clinical Breast Cancer 2019; 19(4): e522 doi: 10.1016/j.clbc.2019.03.006
|
| 30 |
Lianyu Chen, Jie Fan, Hao Chen, Zhiqiang Meng, Zhen Chen, Peng Wang, Luming Liu. The IL-8/CXCR1 axis is associated with cancer stem cell-like properties and correlates with clinical prognosis in human pancreatic cancer cases. Scientific Reports 2014; 4(1) doi: 10.1038/srep05911
|
| 31 |
Jelena Milovanović, Nataša Todorović-Raković, Tijana Vujasinović, Zaki Abu Rabi. Interleukin 8 in progression of hormone-dependent early breast cancer. Journal of Biosciences 2017; 42(2): 265 doi: 10.1007/s12038-017-9679-4
|
| 32 |
Jacek R. Wilczyński, Marek Nowak. Interaction of Immune and Cancer Cells. Experientia Supplementum 2022; 113: 1 doi: 10.1007/978-3-030-91311-3_1
|
| 33 |
Ludwig G. Strauss. Level of TNF-related apoptosis-inducing-ligand and CXCL8 correlated with 2-[18F]Fluoro-2-deoxy-D-glucose uptake in anti-VEGF treated colon cancers. Medical Science Monitor 2013; 19: 875 doi: 10.12659/MSM.889605
|
| 34 |
Vikash Chandra, Angeliki Karamitri, Paul Richards, Françoise Cormier, Cyrille Ramond, Ralf Jockers, Mathieu Armanet, Olivier Albagli-Curiel, Raphael Scharfmann. Extracellular acidification stimulates GPR68 mediated IL-8 production in human pancreatic β cells. Scientific Reports 2016; 6(1) doi: 10.1038/srep25765
|
| 35 |
Arseniy E. Yuzhalin, Anton G. Kutikhin. Interleukins in Cancer Biology. 2015; : 291 doi: 10.1016/B978-0-12-801121-8.00009-9
|
| 36 |
Erik Johnson, Walid Yassin, Michelle Guignet. Biomarkers of Brain Injury and Neurological Disorders. 2014; : 304 doi: 10.1201/b17644-13
|
| 37 |
Zeting Huang, Bin Zhou, Zheng Li, Cantong Liu, Chunwen Zheng, Ruijie Zeng, Chaoqun Hong, Liyan Xu, Enmin Li, Yuhui Peng, Yiwei Xu. Serum interleukin-8 as a potential diagnostic biomarker in esophageal squamous cell carcinoma. Cancer Biomarkers 2020; 29(1): 139 doi: 10.3233/CBM-201687
|
| 38 |
Ioan Roman, Maria-Laura Soare, Roxana Doina Trusca, Corneliu Fratila, Elzbieta Krasicka-Cydzik, Miruna-Silvia Stan, Anca Dinischiotu. Electrochemical Biosensitivity of Titania Nanotubes towards Alkaline Phosphatase, IL-6 and IL-8 Interleukins Biomarkers. Journal of The Electrochemical Society 2014; 161(14): B275 doi: 10.1149/2.0071414jes
|
| 39 |
Ali Ajdari, Yunhe Xie, Christian Richter, Maximilian Niyazi, Dan G. Duda, Theodore S. Hong, Thomas Bortfeld. Toward Personalized Radiation Therapy of Liver Metastasis: Importance of Serial Blood Biomarkers. JCO Clinical Cancer Informatics 2021; (5): 315 doi: 10.1200/CCI.20.00118
|
| 40 |
Sandeep Pandey, Ranjana Singh, Nimra Habib, Vivek Singh, Rashmi Kushwaha, Anil K Tripathi, Abbas A Mahdi. Expression of CXCL8 (IL-8) in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia Patients. Cureus 2023; doi: 10.7759/cureus.45929
|
| 41 |
Miguel F. Sanmamed, Omar Carranza-Rua, Carlos Alfaro, Carmen Oñate, Salvador Martín-Algarra, Guiomar Perez, Sara F. Landazuri, Álvaro Gonzalez, Stefanie Gross, Inmaculada Rodriguez, Cecilia Muñoz-Calleja, María Rodríguez-Ruiz, Bruno Sangro, José M. López-Picazo, Manglio Rizzo, Guillermo Mazzolini, Juan I. Pascual, Maria Pilar Andueza, Jose Luis Perez-Gracia, Ignacio Melero. Serum Interleukin-8 Reflects Tumor Burden and Treatment Response across Malignancies of Multiple Tissue Origins. Clinical Cancer Research 2014; 20(22): 5697 doi: 10.1158/1078-0432.CCR-13-3203
|
| 42 |
Hemanth K. Kandikattu, Sathisha U. Venkateshaiah, Anil Mishra. Chronic Pancreatitis and the Development of Pancreatic Cancer. Endocrine, Metabolic & Immune Disorders - Drug Targets 2020; 20(8): 1182 doi: 10.2174/1871530320666200423095700
|
| 43 |
Deirdré Kruger, Yandiswa Y. Yako, John Devar, Nicola Lahoud, Martin Smith, Surinder K. Batra. Inflammatory cytokines and combined biomarker panels in pancreatic ductal adenocarcinoma: Enhancing diagnostic accuracy. PLOS ONE 2019; 14(8): e0221169 doi: 10.1371/journal.pone.0221169
|
| 44 |
Ryan Clay, Shadab A. Siddiqi. Theranostic Approach for Pancreatic Cancer. 2019; : 325 doi: 10.1016/B978-0-12-819457-7.00016-5
|
| 45 |
Touseef Rehan, David MacEwan, Nasrullah Shah, Tabassum Rehan, Riffat Tahira, Sheeba Murad, Mariam Anees, Iram Murtaza, Muhammad Farman, Obaid-ur-Rahman Abid, Aneesa Sultan. Apoptosis of Leukemia Cells by Ocimum basilicum Fractions Following TNF alpha Induced Activation of JNK and Caspase 3. Current Pharmaceutical Design 2019; 25(34): 3681 doi: 10.2174/1381612825666191011100826
|
| 46 |
Shintaro Tsukinaga, Mikio Kajihara, Kazuki Takakura, Zensho Ito, Tomoya Kanai, Keisuke Saito, Shinichiro Takami, Hiroko Kobayashi, Yoshihiro Matsumoto, Shunichi Odahara, Kan Uchiyama, Hiroshi Arakawa, Masato Okamoto, Haruo Sugiyama, Kazuki Sumiyama, Toshifumi Ohkusa, Shigeo Koido. Prognostic significance of plasma interleukin-6/-8 in pancreatic cancer patients receiving chemoimmunotherapy. World Journal of Gastroenterology 2015; 21(39): 11168-11178 doi: 10.3748/wjg.v21.i39.11168
|
| 47 |
Yu-Shu Liu, Jhih-Wen Hsu, Hsiao-Yun Lin, Sheng-Wei Lai, Bor-Ren Huang, Cheng-Fang Tsai, Dah-Yuu Lu. Bradykinin B1 receptor contributes to interleukin-8 production and glioblastoma migration through interaction of STAT3 and SP-1. Neuropharmacology 2019; 144: 143 doi: 10.1016/j.neuropharm.2018.10.033
|
| 48 |
Mohammad Aslam Khan, Sanjeev K. Srivastava, Arun Bhardwaj, Seema Singh, Sumit Arora, Haseeb Zubair, James E. Carter, Ajay P. Singh. Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. Oncotarget 2015; 6(36): 39140 doi: 10.18632/oncotarget.3784
|
| 49 |
JUNPU WANG, WANMING HU, XIAOYING WU, KUANSONG WANG, JUN YU, BAIHUA LUO, GENGQIU LUO, WEIYUAN WANG, HUILING WANG, JINGHE LI, JIFANG WEN. CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and EKR1/2 phosphorylation. International Journal of Oncology 2016; 48(5): 2184 doi: 10.3892/ijo.2016.3428
|
| 50 |
Daniel R. Principe, Brian DeCant, Andrew M. Diaz, Riley J. Mangan, Rosa Hwang, Andrew Lowy, Brandon B. Shetuni, Bharath K. Sreekumar, Chuhan Chung, David J. Bentrem, Hidayatullah G. Munshi, Barbara Jung, Paul J. Grippo, Faraz Bishehsari. PEDF inhibits pancreatic tumorigenesis by attenuating the fibro-inflammatory reaction. Oncotarget 2016; 7(19): 28218 doi: 10.18632/oncotarget.8587
|
| 51 |
Aravinthan Adithan, Judith Sharmila John Peter, Amjad Hossain Mohammad, Bumseok Kim, Chang-Won Kang, Nam Soo Kim, Ki-Chul Hwang, Jong-Hoon Kim. A gastric cancer cell derived extracellular compounds suppresses CD161+CD3- lymphocytes and aggravates tumor formation in a syngeneic mouse model. Molecular Immunology 2020; 120: 136 doi: 10.1016/j.molimm.2020.02.016
|
| 52 |
Ning Pu, Qiangda Chen, Jicheng Zhang, Hanlin Yin, Dansong Wang, Yuan Ji, Shengxiang Rao, Tiantao Kuang, Xuefeng Xu, Wenchuan Wu, Wenhui Lou. Circulating cytokines allow for identification of malignant intraductal papillary mucinous neoplasms of the pancreas. Cancer Medicine 2023; 12(4): 3919 doi: 10.1002/cam4.5051
|
| 53 |
Shuhei Mayanagi, Minoru Kitago, Toshiharu Sakurai, Tatsuo Matsuda, Tomonobu Fujita, Hajime Higuchi, Junichi Taguchi, Hiroya Takeuchi, Osamu Itano, Koichi Aiura, Yasuo Hamamoto, Hiromasa Takaishi, Masato Okamoto, Makoto Sunamura, Yutaka Kawakami, Yuko Kitagawa. Phase I pilot study of Wilms tumor gene 1 peptide‐pulsed dendritic cell vaccination combined with gemcitabine in pancreatic cancer. Cancer Science 2015; 106(4): 397 doi: 10.1111/cas.12621
|
| 54 |
Krishna Sriram, Cristina Salmerón, Shu Z. Wiley, Paul A. Insel. GPCRs in pancreatic adenocarcinoma: Contributors to tumour biology and novel therapeutic targets. British Journal of Pharmacology 2020; 177(11): 2434 doi: 10.1111/bph.15028
|
| 55 |
Cong-Jun Wang, Rong-Hua Xu, Qiong-Ying Yuan, Yong-Kun Wang, Dong-Wei Shen, Xu-Jing Wang, Wei Gao, Hui Zhang, Hua Jiang. Bioinformatics Method to Analyze the Mechanism of Pancreatic Cancer Disorder. Journal of Computational Biology 2013; 20(6): 444 doi: 10.1089/cmb.2012.0281
|
| 56 |
Mark B. Wiley, Kunaal Mehrotra, Jessica Bauer, Cemal Yazici, Agnieszka B. Bialkowska, Barbara Jung. Acute Pancreatitis. Pancreas 2023; 52(6): e335 doi: 10.1097/MPA.0000000000002259
|
| 57 |
Yoh Zen. Type 2 Autoimmune Pancreatitis: Consensus and Controversies. Gut and Liver 2022; 16(3): 357 doi: 10.5009/gnl210241
|
| 58 |
XUANZHONG ZHAO, FENG WANG, MINGXING HOU. Expression of stem cell markers nanog and PSCA in gastric cancer and its significance. Oncology Letters 2016; 11(1): 442 doi: 10.3892/ol.2015.3884
|
| 59 |
Naomi D’souza, Jorge Sans Burns, Giulia Grisendi, Olivia Candini, Elena Veronesi, Serena Piccinno, Edwin M. Horwitz, Paolo Paolucci, Pierfranco Conte, Massimo Dominici. Mesenchymal Stem Cells - Basics and Clinical Application II. Advances in Biochemical Engineering/Biotechnology 2012; 130: 209 doi: 10.1007/10_2012_150
|
| 60 |
Rozita Roshani, Fiona McCarthy, Thorsten Hagemann. Inflammatory cytokines in human pancreatic cancer. Cancer Letters 2014; 345(2): 157 doi: 10.1016/j.canlet.2013.07.014
|
| 61 |
Hyoung Woo Kim, Jong-chan Lee, Kyu-hyun Paik, Jingu Kang, Jaihwan Kim, Jin-Hyeok Hwang. Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern. Medicine 2017; 96(5): e5926 doi: 10.1097/MD.0000000000005926
|
| 62 |
Ala Litman-Zawadzka, Marta Łukaszewicz-Zając, Barbara Mroczko. Novel potential biomarkers for pancreatic cancer – A systematic review. Advances in Medical Sciences 2019; 64(2): 252 doi: 10.1016/j.advms.2019.02.004
|
| 63 |
Shih-Mo Yang, Qiang Lin, Hongbo Zhang, Ruixue Yin, Wenjun Zhang, Minchao Zhang, Yubao Cui. Dielectrophoresis assisted high-throughput detection system for multiplexed immunoassays. Biosensors and Bioelectronics 2021; 180: 113148 doi: 10.1016/j.bios.2021.113148
|
| 64 |
Xiaojie Wu, Molly A. Newbold, Zhe Gao, Christy L. Haynes. A versatile microfluidic platform for the study of cellular interactions between endothelial cells and neutrophils. Biochimica et Biophysica Acta (BBA) - General Subjects 2017; 1861(5): 1122 doi: 10.1016/j.bbagen.2017.02.012
|
| 65 |
Saeed Farajzadeh Valilou, Mahsa Keshavarz-Fathi, Nicola Silvestris, Antonella Argentiero, Nima Rezaei. The role of inflammatory cytokines and tumor associated macrophages (TAMs) in microenvironment of pancreatic cancer. Cytokine & Growth Factor Reviews 2018; 39: 46 doi: 10.1016/j.cytogfr.2018.01.007
|
| 66 |
Pablo Hernández-Camarero, Elena López-Ruiz, Carmen Griñán-Lisón, María Ángel García, Carlos Chocarro-Wrona, Juan Antonio Marchal, Julian Kenyon, Macarena Perán. Pancreatic (pro)enzymes treatment suppresses BXPC-3 pancreatic Cancer Stem Cell subpopulation and impairs tumour engrafting. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-47837-7
|
| 67 |
Roula Antoon, Xing-Hua Wang, Amr H. Saleh, Jenny Warrington, David W Hedley, Armand Keating. Pancreatic cancer growth promoted by bone marrow mesenchymal stromal cell–derived IL-6 is reversed predominantly by IL-6 blockade. Cytotherapy 2022; 24(7): 699 doi: 10.1016/j.jcyt.2021.12.005
|
| 68 |
Shikha Gaur, Yafan Wang, Leo Kretzner, Linling Chen, Terence Yen, Xiwei Wu, Yate-Ching Yuan, Mark Davis, Yun Yen. Pharmacodynamic and pharmacogenomic study of the nanoparticle conjugate of camptothecin CRLX101 for the treatment of cancer. Nanomedicine: Nanotechnology, Biology and Medicine 2014; 10(7): 1477 doi: 10.1016/j.nano.2014.04.003
|
| 69 |
Nataša Todorović-Raković, Jelena Milovanović. Interleukin-8 in Breast Cancer Progression. Journal of Interferon & Cytokine Research 2013; 33(10): 563 doi: 10.1089/jir.2013.0023
|
| 70 |
Current World Literature. Current Opinion in Organ Transplantation 2013; 18(1): 111 doi: 10.1097/MOT.0b013e32835daf68
|
| 71 |
Tomi Akinyemiju, Justin X. Moore, Daniel Tefera Dibaba, Maria Pisu, Michael Goodman, Virginia J. Howard, Monika Safford, Susan C. Gilchrist, Mary Cushman, LeAnn Long, Suzanne E. Judd. Association of baseline inflammatory biomarkers with cancer mortality in the REGARDS cohort. Oncotarget 2019; 10(47): 4857 doi: 10.18632/oncotarget.27108
|
| 72 |
Marta Łukaszewicz-Zając, Mariusz Gryko, Barbara Mroczko. The role of selected chemokines and their specific receptors in pancreatic cancer. The International Journal of Biological Markers 2018; 33(2): 141 doi: 10.1177/1724600817753094
|
| 73 |
XIAOLEI ZHAI, QIANHE HAN, ZHONGJIE SHAN, XIAOWEI QU, LIANG GUO, YUDONG ZHOU. Dual specificity phosphatase 6 suppresses the growth and metastasis of prostate cancer cells. Molecular Medicine Reports 2014; 10(6): 3052 doi: 10.3892/mmr.2014.2575
|
| 74 |
Cui-Ping Tang, Han-Jing Zhou, Jian Qin, Yi Luo, Tao Zhang. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer. Oncology Reports 2017; 38(5): 3144 doi: 10.3892/or.2017.5968
|
| 75 |
Ala Litman-Zawadzka, Marta Łukaszewicz-Zając, Mariusz Gryko, Agnieszka Kulczyńska-Przybik, Bogusław Kędra, Barbara Mroczko. Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer. International Journal of Molecular Sciences 2020; 21(17): 6193 doi: 10.3390/ijms21176193
|
| 76 |
Emelie Karnevi, Roland Andersson, Ann H Rosendahl. Tumour‐educated macrophages display a mixed polarisation and enhance pancreatic cancer cell invasion. Immunology & Cell Biology 2014; 92(6): 543 doi: 10.1038/icb.2014.22
|
| 77 |
Victoria E Shaw, Brian Lane, Claire Jenkinson, Trevor Cox, William Greenhalf, Christopher M Halloran, Joseph Tang, Robert Sutton, John P Neoptolemos, Eithne Costello. Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease. Molecular Cancer 2014; 13(1) doi: 10.1186/1476-4598-13-114
|
| 78 |
Yandiswa Yolanda Yako, Deirdré Kruger, Martin Smith, Martin Brand, Francisco X. Real. Cytokines as Biomarkers of Pancreatic Ductal Adenocarcinoma: A Systematic Review. PLOS ONE 2016; 11(5): e0154016 doi: 10.1371/journal.pone.0154016
|
| 79 |
Saheli Sarkar, Pooja Sabhachandani, Tania Konry. Rolling Circle Amplification (RCA). 2016; : 85 doi: 10.1007/978-3-319-42226-8_8
|
| 80 |
Huifeng Liao, Huayan Li, Jin Song, Hongye Chen, Huiyan Si, Junhua Dong, Jiandong Wang, Xue Bai. Expression of the prognostic marker IL‐8 correlates with the immune signature and epithelial‐mesenchymal transition in breast cancer. Journal of Clinical Laboratory Analysis 2023; 37(3) doi: 10.1002/jcla.24797
|
| 81 |
David B. Shultz, Jonathan Pai, Wayland Chiu, Kendall Ng, Madeline G. Hellendag, Gregory Heestand, Daniel T. Chang, Dongsheng Tu, Malcolm J. Moore, Wendy R. Parulekar, Albert C. Koong, Anthony W.I. Lo. A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3. PLOS ONE 2016; 11(1): e0147995 doi: 10.1371/journal.pone.0147995
|
| 82 |
Yingkun Xu, Yang Peng, Meiying Shen, Li Liu, Jinwei Lei, Shun Gao, Yuan Wang, Ailin Lan, Han Li, Shengchun Liu, Faisal Raza. Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients. Journal of Oncology 2022; 2022: 1 doi: 10.1155/2022/1525245
|